In a case of a 75-year-old man with stage IIIC (T3N3M0) squamous cell carcinoma of the right lower lobe and mediastinal lymph nodes (red arrows), durvalumab, an anti-PD-L1 ICI, was administered as a consolidation treatment after the completion of CCRT without progression. Here, CD274 is linked to squamous cell carcinoma.